Skip to main content


Fig. 8 | Stem Cell Research & Therapy

Fig. 8

From: Chrysosplenetin promotes osteoblastogenesis of bone marrow stromal cells via Wnt/β-catenin pathway and enhances osteogenesis in estrogen deficiency-induced bone loss

Fig. 8

Chrysosplenetin inhibit ovariectomy estrogen deficiency-induced bone resorption. a Representative 3D reconstruction image and micro-CT analysis of trabecular bone microarchitecture from the femur of sham mice, OVX mice, and test group treated with Chrysosplenetin at 3 mg/kg. The result shows the potential protective effect of Chrysosplenetin in OVX-induced osteoporosis. b Quantitative analyses of bone volume/total volume (BV/TV), trabecular number (Tb.N*), trabecular thickness (Tb.Th*), and trabecular separation (Tb.Sp*) (n = 6) (CHR Chrysosplenetin; *p < 0.05, **p < 0.01 relative to OVX untreated controls)

Back to article page